Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in Ramadan

NCT03349840 PHASE4 TERMINATED

This is a study to be performed in Qatar that will look at the comparison of glycemic control in patients with type 2 diabetes on insulin glargine U100 with insulin degludec over the Ramadan period, to determine whether better glycemic control with fewer hypoglycemic episodes can be achieved.

Details

Lead sponsor	Weill Cornell Medical College in Qatar
Phase	PHASE4
Status	TERMINATED
Enrolment	273
Start date	Sun Jan 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Dec 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Type2 Diabetes

Interventions

• Insulin Degludec U100
• Insulin Glargine

Countries

Qatar